Seeing Is Believing
Healthcare - Sector
ARWR is currently covered by 8 analysts with an average price target of $88.75. This is a potential upside of $19.63 (28.4%) from yesterday's end of day stock price of $69.12.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 258 price targets and 201 ratings on display. The stock rating distribution of ARWR is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 80.88% with an average time for these price targets to be met of 379.74 days.
Highest price target for ARWR is $110, Lowest price target is $17, average price target is $65.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 13-Jan-2026. First documented stock forecast 05-Mar-2014.
Currently out of the existing stock ratings of ARWR, 16 are a BUY (80%), 4 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Nov-2017
$110
$42.95 (64.06%)
$100
16 days ago
(13-Jan-2026)
29/39 (74.36%)
$44.45 (67.81%)
286
Buy Since 16-Sep-2020
$80
$12.95 (19.31%)
$60
22 days ago
(07-Jan-2026)
20/24 (83.33%)
$14.31 (21.78%)
453
Hold Since 30-Nov-2023
$81
$13.95 (20.81%)
$48
22 days ago
(07-Jan-2026)
3/5 (60%)
$15.31 (23.31%)
32
Buy Since 04-Dec-2023
$62
$-5.05 (-7.53%)
$41
1 months 28 days ago
(01-Dec-2025)
5/5 (100%)
$9.3 (17.65%)
194
Buy Since 12-May-2020
$52
$-15.05 (-22.45%)
$40
2 months 10 days ago
(19-Nov-2025)
10/12 (83.33%)
$11.53 (28.49%)
395
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?